Nippon Zenyaku Kogyo Co., Ltd.

Development, manufacturing, import, export and sales of veterinary pharmaceuticals etc,Biopharmaceutical contract manufacturing

Original products: Allermmune HDM, KOEN (Mineral Salt Block), CELLBANKER etc
Products for distribution: FRONTLINE, NexGard, Cardomec (Heartguard) etc

We continue our management innovation through improvements in quality management
(ZENOAQ is the first company in Tohoku and Hokkaido regions to receive the Japan Quality Award 2016)

ZENOAQ is the only veterinary pharmaceutical company in Japan with a direct sales system, allowing direct access to the market and our customers. We have 34 sales bases in Japan as well as manufacturing and sales bases in China, enabling us to import and export products from/to a variety of companies worldwide.

Nippon Zenyaku Kogyo (ZENOAQ) is the largest veterinary pharmaceutical company headquartered in Koriyama City, Fukushima prefecture.
We launched Allermmune HDM in Japan in 2014. This is the world’s first desensitization therapy for house dust mite-induced canine atopic dermatitis, and this achievement has motivated us to put further effort on developing new bio-drugs.
We celebrated our 70th anniversary last year and we received the Japan Quality Award 2016. We continue working as an award-winning company to become an invaluable company for customers.

* Production of recombinant proteins in a cutting-edge biological manufacturing plant - manufacturing within this plant maximizes the utilization of the single-use bioreactor system for large-scale mammalian cell culture and purification in compliance with JP-GMP, cGMP and EU-GMP.
* The world’s-leading solidification technology of salts and minerals ? we collaborated with Nippon Steel & Sumikin Metal Products Co., Ltd to innovate a wild deer attract YUKURU, which has received the Good Design Award 2016 and the Chairperson's Award, Eco-Products Awards Steering Committee 2016.